ORCL has collapsed ~40% from peak levels and now trades at a meaningful discount to its fundamental growth trajectory, with the market pricing in maximum fear around the $40B capital raise and negative FCF while ignoring a $638B RPO backlog, 93% OCI growth, and strong FY2027 guidance. At $148.53, the post-earnings capitulation appears exhausted after five consecutive sessions of institutional distribution, creating a contrarian entry point where bad news is largely priced in and any stabilization in sentiment or positive Q1 FY2027 data could trigger a sharp mean-reversion bounce. Larry Ellison's deep political ties to the Trump administration [N3] further de-risk the government contract pipeline, providing a durable non-commercial revenue anchor that the market is currently discounting.